Preclinical Development of a Novel Radio-labeled Therapeutic for Treating Breast Cancer Brain Metastasis
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
Cereius, Inc.
Award Date
Award Amount
500,000
Program Name
Strategic Growth Loan
Program Category
Business Financing
Principal Investigator
Ed Field
Fiscal Year
2020
Region
Research Triangle
Project Description:
Cereius is developing a novel platform of radio-labeled, brain-penetrant targeting peptides that will address solid tumor brain metastasis. The initial therapeutic focus will be treatment of HER2-positive breast cancer brain metastases. The company was awarded a $500,000 SGL to fund IND-enabling studies to advance into human patient clinical studies.